Conferences

Catalog

Abstracts

Calendar

Best of Hematology and Breast Cancer™ 2026, Boise

Accreditation: 6.75 Nursing Contact Hours | 6.75 ABIM MOC II | 6.75 AMA PRA Category 1 Credit™ | 6.75 ACPE Pharmacy

Venue: The Grove Hotel, 245 South Capitol Boulevard, Boise, ID, 83702, United States

Start Date: February 28, 2026

Claim Now

Overview

Trusted by Thousands of Attendees
Across Our Events

51+

Email if you have questions

Our Speakers

Planning Committee

Christos Vaklavas, MD

Conference Chair

Huntsman Cancer Institute of the University of Utah

Travis G Williams, DO

Conference Chair

St Lukes Cancer Institute

Andrew Scott Pierson, MD

Conference Chair

Saint Alphonsus Health Alliance

Faculty

Andrew Scott Pierson, MD

Session Chair

Saint Alphonsus Health Alliance

Roland B. Walter, MD, PhD

Session Chair

Fred Hutchinson Cancer Center

Travis Williams, DO

Session Chair

Leila Khaddour, MD

Session Chair

Saint Alphonsus Medical Group

Clinton Roy Morgan, MD

Session Chair

St. Luke's Cancer Institute

Patricia Avancena, MD, PhD

Session Chair

Rebecca Silbermann, MD

Faculty

Oregon Health & Science University

Namita Chittoria, MD

Faculty

University of Utah

Ghulam Rehman Mohyuddin, MD

Faculty

University of Utah

Jairam Krishnamurthy, MD

Faculty

University of Nebraska medical center

Mei Wei, MD

Faculty

University of Utah

Roma Bhatia, MD

Faculty

University of Utah/Huntsman Cancer Institute

Robert Mancini, PharmD

Faculty

Bart L Scott, MD

Faculty

Fred Hutchinson Cancer Research Center

Nicole Birrer, MD

Faculty

Rachel Davis

Faculty

Sara Zhukovsky, MD

Faculty

Huntsman Cancer Institute at University of Utah

Jordan Fenlon, MD

Faculty

Stephen Spurgeon, MD

Faculty

Oregon Health and Science University

RHIANA MENEN, MD

Faculty

Mountain State Breast and General Surgery

RHIANA MENEN, MD

Faculty

Mountain State Breast and General Surgery

Ming Y Lim, MBBCh

Faculty

University of Utah School of Medicine

Ryan Cassaday, MD

Faculty

University of Washington & Fred Hutch Cancer Center

Daniel Couriel, MD, MBA

Faculty

University of Utah

Agenda

Saturday, February 28th, 2026

All timings are in Mountain Time (MDT, GMT-06:00) time.

07:00 AM - 08:00 AMRegistration, Exhibits, & Breakfast

08:00 AM - 08:05 AMWelcome

08:05 AM - 08:20 AMBinaytara's Efforts in Improving Cancer Care Disparities - Bhawana Srivastava

08:20 AM - 09:20 AMSession 1: Updates in Classical Hematology

Session Chair: Andrew Scott Pierson, MD

08:20 AM - 08:40 AM

TTP/HUS – Nicole Birrer, MD

08:40 AM - 09:00 AM

Modern Topics in Hemophilia – Ming Y Lim, MBBCh

09:00 AM - 09:20 AM

Case-Based Panel Discussion, PNH – Nicole Birrer, MD

09:20 AM - 10:20 AMSession 2: Acute Leukemia

Session Chair: Roland B. Walter, MD, PhD

09:20 AM - 09:35 AM

AML / MDS – Roland B. Walter, MD, PhD

09:35 AM - 09:50 AM

ALL – Ryan Cassaday, MD

09:50 AM - 10:20 AM

Case-Based Panel Discussion – Rachel Davis

10:20 AM - 11:05 AMBreak & Exhibits - Product Theater sponsored by JNJ (non-CME accredited): Making the Case for Early Use of CAR-T Therapy in Multiple Myeloma - Karolina Faysman, NP, UCLA Health ROOM: Flichel

11:05 AM - 12:05 PMSession 3: Lymphoma

Session Chair: Travis Williams, DO

11:05 AM - 11:20 AM

B-Cell Lymphoma – Travis Williams, DO

11:20 AM - 11:35 AM

CLL – Stephen Spurgeon, MD

11:35 AM - 11:50 AM

Outpatient Bispecific Management – Robert Mancini, PharmD

11:50 AM - 12:05 PM

Case-Based Panel Discussion, Practical Issues with Bispecifics – Rachel Davis

12:05 PM - 12:50 PMSession 4: Multiple Myeloma

Session Chair: Leila Khaddour, MD

12:05 PM - 12:20 PM

Frontline Therapy of Multiple Myeloma – Rebecca Silbermann, MD

12:20 PM - 12:35 PM

Relapsed/Recurrent Sequencing Multiple Myeloma – Ghulam Rehman Mohyuddin, MD

12:35 PM - 12:50 PM

Case-Based Panel Discussion

12:50 PM - 01:50 PMLunch & Exhibits - Product Theater sponsored by Natera (non-CME accredited): From Signal to Strategy: How ctDNA testing with Signatera Is Changing Oncology Care - Dr. Angel Rodriguez, MD ROOM: Flichel

01:50 PM - 02:35 PMSession 5: Hematologic Malignancies

Session Chair: Clinton Roy Morgan, MD

01:50 PM - 02:05 PM

MPN – Bart L Scott, MD

02:05 PM - 02:20 PM

Use of Cell Therapy in Non-Malignant Conditions – Daniel Couriel, MD, MBA

02:20 PM - 02:35 PM

Case-Based Panel Discussion – Leila Khaddour, MD

02:35 PM - 03:50 PMSession 6: Metastatic Disease, Local Therapy & Survivorship

02:35 PM - 02:50 PM

What's Next After CDK4/6? ER+/HER2- Metastatic Breast Cancer – Christos Vaklavas, MD

02:50 PM - 03:05 PM

Are we Finally Winning in Triple-Negative Breast Cancer? – Namita Chittoria, MD

03:05 PM - 03:20 PM

Less May be More: De-escalation in HER2+ Disease – Mei Wei, MD

03:20 PM - 03:35 PM

Beyond Survival: Fertility, Survivorship, & Managing Toxicities – Roma Bhatia, MD

03:35 PM - 03:50 PM

New Kids on the Block: Antibody Drug Conjugates – Christos Vaklavas, MD

03:50 PM - 04:05 PMBreak & Exhibits

Acknowledgement of Commerical Support

This activity is supported with Independent Medical Education grants from:

Gilead
Stemline Therapeutics, Inc

About Best of Hematology and Breast Cancer™ 2026, Boise

Overview

Faculty and committee

Our Speakers

Planning Committee

Faculty

Conference program and agenda

Agenda

Venue and map

Accreditations and continuing education

Acknowledgement of Commerical Support

Registration and pricing

Exhibitors and sponsorship